John Ebos, PhD

Assistant Professor of Oncology
Department of Cancer Genetics and Genomics
Department of Medicine
Department of Pharmacology and Therapeutics (Graduate Program)
Roswell Park Comprehensive Cancer Center
Special Interests: 
Assessment of host and tumor contributions to efficacy and drug resistance following antiangiogenic and immune-checkpoint treatment.
Development of clinically relevant mouse models of advanced metastatic disease.
Discovery of biomarkers to aid in clinical optimization of VEGF and PD-1 pathway inhibitor use.


Dr. Ebos completed his undergraduate training at McGill University (B.Sc Biology; philosophy minor) and earned his Ph.D. in the Department of Medical Biophysics at the University of Toronto where he studied novel circulating molecules as potential surrogate markers of cancer progression and antiangiogenic drug efficacy.


Education and Training: 
Ph.D.—Medical Biophysics, University of Toronto, Toronto, Canada
B.Sc.—Biology, McGill University, Montreal, Canada